Biotech · Private company
Cognito Therapeutics, Inc.
Track this companyFree. Adds Cognito Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- GammaSense Stimulation System (Active Settings)Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- GammaSense Stimulation System (non-invasive, non-significant risk)Alzheimer Disease, Early OnsetClinicalTrials.gov · fetched Nov 12, 2026
- GammaSense Stimulation System (Sham Settings)Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sensory Stimulation System (GS120) - ActiveAlzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Spectris™ AD - ActiveAlzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Spectris™ AD - ShamAlzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)NA · ENROLLING_BY_INVITATION · started Feb 29, 2024ClinicalTrials.gov NCT06245031 · fetched Nov 12, 2026
- A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)NA · COMPLETED · started Dec 13, 2022ClinicalTrials.gov NCT05637801 · fetched Nov 12, 2026
- Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)NA · UNKNOWN · started May 31, 2018ClinicalTrials.gov NCT03661034 · fetched Nov 12, 2026
- Multi-Center Study of Sensory Stimulation to Improve Brain FunctionNA · ACTIVE_NOT_RECRUITING · started Apr 24, 2018ClinicalTrials.gov NCT03556280 · fetched Nov 12, 2026